Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,257.1
9.9 (0.31%)

 

  • STI Straits Times Index
    3,257.1
    9.9 (0.31%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,579.8
    -7.5 (-0.47%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,341.0
    355.7 (1.27%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,060.8
    8.6 (0.28%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,031.3
    166.8 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,234.5
    -3.6 (-0.06%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,267.2
    27.6 (1.23%)
    Index delayed 20 minutes
  • XAO XAO
    7,249.0
    68.5 (0.95%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,420.7M
  • Value: 799.8M
  • Rise: 141
  • Fall: 166
  • Unch: 512

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.101+0.009
AsiaMedic0.017-0.001
Healthway Med0.043+0.003
P5 Capital0.034-0.001
AusGroup^0.044-0.001
Ntegrator Intl0.015+0.002
Thomson Medical0.063-
YZJ Shipbldg SGD1.100-
Golden Agri-Res0.235+0.005
DISA0.003-

World Indices

World Indices
Name Last Change
Nasdaq 9,370.8 -18.1
HSI 28,341.0 +355.7
HSCEI 11,174.7 +204.6
Jakarta 6,235.2 -3.0
Nikkei 225 24,031.3 +166.8
SSE Comp 3,060.8 +8.6
Shanghai A 3,207.1 +9.0
Shanghai B 257.5 +0.2
PSE Comp 0.0
KOSPI 2,267.2 +27.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

WUXI BIO WUXI BIO
Quotes 15 Minutes Delayed. Updated at 22 Jan 2020 16:08
Last (HKD): 104.500 Change: +0.500 High: 106.500 Remarks: -
Change (%): +0.48 Low: 104.100
Open 105.000 Yesterday's Close 104.000
Buy Price 104.500 Sell Price 104.500
Buy Volume ('000) 128.5 Sell Volume ('000) 223.5
Cumulative Volume ('000) 2,582.94 Cumulative Value 271,142,896
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.58096 Trailing EPS (HKD) e 0.74314 NAV (HKD) b 7.5563
PE a 179.875 Trailing PE f 140.620 Price / NAV b 13.8295
Dividend (HKD) d - Cash In Hand (HKD) g 2.5426 Issued & Paid-up Shares c 1,285,640,322
Dividend Yield (%) d - Price / Cash In Hand g 41.100 Treasury Shares h 11,749,678
Beta - 75 Daysi 0.779 R-Squared - 75 Days(%)i 9.41 Market Cap (M) 134,349.414
Beta - 500 Daysi 1.213 R-Squared - 500 Days (%)i 19.77 Enterprise Value (M) 131,156.826
Piotroski F Score 5 Exchange Code 2269 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 30.11 6-Month VWAP 88.963 Free Float (%) 60.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 21 Jan 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 23 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference WUXI BIO HKEx 134,349.414 179.875 140.620 13.8295 -
Industry Biotechnology HKEx 48,778.629 15.007 16.029 6.4200 2.435
Local Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Local Peer SINO BIOPHARM HKEx 151,866.775 14.173 14.710 4.5227 0.606
Local Peer BEIGENE HKEx 102,173.400 - - 10.1944 -
Local Peer GENSCRIPT BIO HKEx 34,257.426 206.015 - 9.6607 -
Local Peer 3SBIO HKEx 28,955.658 19.141 23.298 2.8539 -
Local Peer HAOHAI BIOTEC HKEx 13,358.362 27.206 30.152 3.1451 0.779
Local Peer ALPHAMAB-B HKEx 13,489.261 - - -37.8533 -
Local Peer FRONTAGE HKEx 8,813.540 100.046 100.038 4.5615 -
Local Peer CKLIFE SCIENCES HKEx 8,457.742 32.164 32.119 2.0258 1.136
Local Peer VIVA BIOTECH HKEx 7,121.899 66.405 66.403 3.6974 -
Local Peer ASCENTAGE-B HKEx 5,885.038 - - -3.1868 -
Local Peer SINOMAB BIO-B HKEx 4,145.709 - - - -
Other Local Peers ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 141,178.118 16.819 17.501 12.9201 2.355
Global Peer CSL ASX 138,131.100 51.485 51.485 18.4589 0.872
Global Peer GILEAD SCIENCES INC NASDAQ 79,236.345 14.525 29.423 3.8457 3.689
Global Peer VERTEX PHARMACEUTICAL NASDAQ 60,170.529 28.702 28.068 11.4536 -
Global Peer BIOGEN INC NASDAQ 51,821.138 11.696 9.604 3.7026 -
Global Peer ILLUMINA INC NASDAQ 48,264.510 58.432 49.604 10.8728 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 39,933.892 16.337 18.624 3.8016 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,795.499 87.961 25.953 5.8541 0.682
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,008.096 322.269 17.009 2.4122 -
Global Peer SEATTLE GENETICS INC NASDAQ 18,624.517 - - 10.4655 -
Other Global Peers INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), NATERA INC (NASDAQ), UNIQURE N.V. (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), EPIZYME INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), XENCOR INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ARVINAS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), REGENXBIO INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), VERACYTE INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), NEXTCURE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), POLYNOVO LIMITED (ASX), ENANTA PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), NANOSTRING TECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), OPKO HEALTH INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), SANGAMO THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), RADIUS HEALTH INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), OMEROS CORP (NASDAQ), KADMON HLDGS INC (NYSE), NANTKWEST INC (NASDAQ), AVROBIO INC (NASDAQ), CYTOKINETICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), IMMUNOGEN INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MACROGENICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AGENUS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MERUS B V (NASDAQ), BELLUS HEALTH INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CABALETTA BIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PERSONALIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), IVERIC BIO INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GERON CORP (NASDAQ), DPHARMA (Bursa), EVOFEM BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), KAMADA (NASDAQ), TELIX PHARMACEUTIC (ASX), LIMINAL BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), AFFIMED N V (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), XOMA CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CHIASMA INC (NASDAQ), IMV INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ATHERSYS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), FIVE PRIME THERAPEUTICS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), NOVAVAX INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), SAVARA INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PYC THERAPEUTICS LIMITED (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), ENZO BIOCHEM INC (NYSE), FENNEC PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), AXCELLA HEALTH INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ADURO BIOTECH INC (NASDAQ), OTONOMY INC (NASDAQ), IMUGENE LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), COHBAR INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFLARX N V (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CEL-SCI CORP (NYSE American), MICROBOT MEDICAL INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORGENESIS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), TREVENA INC (NASDAQ), IMMUTEP LTD (ASX), EQUILLIUM INC (NASDAQ), VERMILLION INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), GENOCEA BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ORTHOCELL LIMITED (ASX), KEZAR LIFE SCIENCES INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ADVAXIS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), RESTORBIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIONANO GENOMICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), MEMPHASYS LTD (ASX), SIERRA ONCOLOGY INC (NASDAQ), BIOTRON (ASX), UNUM THERAPEUTICS INC (NASDAQ), BIONOMICS LTD (ASX), AEVI GENOMIC MEDIC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), TALI DIGITAL LIMITED (ASX), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ORAGENICS INC (NYSE American), SOPHIRIS BIO INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), IBIO INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), MIRAGEN THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), RHINOMED LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), CORREVIO PHARMA CORP (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED (ASX), SENESTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PATRYS LIMITED (ASX), CELLMID LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), BIOCEPT INC (NASDAQ), TOCAGEN INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), REGENEUS LTD (ASX), CYCLACEL PHARMA IN (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), HEAT BIOLOGICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), CLEVELAND BIOLABS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ADALTA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), TROVAGENE INC (NASDAQ), OPGEN INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), BIOXYNE LIMITED (ASX), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), QT Vascular (SGX), MGRC (Bursa), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), TBG DIAGNOSTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+4.600
+4.60 %
10 Days -+4.000
+3.98 %
20 Days -+5.700
+5.77 %
Medium Term Return 3 Months -+24.450
+30.54 %
6 Months -+22.350
+27.21 %
1 Year -+43.800
+72.16 %
Long Term Return 2 Years -+51.800
+98.29 %
Annualised Return Annualised --
+40.82 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 58.900 - 107.600 Change From 1 Year Low +45.600 % Change From 1 Year Low (%) +77.42
Change From 1 Year High -3.100 % Change From 1 Year High (%) -2.88
2 Years Range 44.500 - 107.600 Change From 2 Years Low +60.000 % Change From 2 Years Low (%) +134.83
Change From 2 Years High -3.100 % Change From 2 Years High (%) -2.88
5 Years Range 25.000 - 107.600 Change From 5 Years Low +79.500 % Change From 5 Years Low (%) +318.00
Change From 5 Years High -3.100 % Change From 5 Years High (%) -2.88
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Wuxi Biologics (Cayman), Inc. is an investment holding company, which engages in the discovery, development and manufacture of biologics services. Its services include testing; clinical drug substance cGMP manufacture; commercial drug substance cGMP manufacture; drug product cGMP fill and finish; antibody drug conjugates; regulatory affairs; and technologies and platforms. The company was founded on May 24, 2010 and is headquartered in Wuxi, China.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Jan 2020 106.200 107.600 103.800 104.000 3,098,913 105.4327
20 Jan 2020 105.300 107.600 105.100 106.200 3,726,093 106.6003
17 Jan 2020 106.100 107.300 104.100 106.000 3,957,191 105.6847
16 Jan 2020 101.000 105.700 101.000 105.500 10,410,062 104.0143
15 Jan 2020 99.800 101.900 98.900 99.900 7,861,374 100.2465
14 Jan 2020 99.800 101.400 98.900 98.950 5,630,879 99.4422
13 Jan 2020 98.100 99.800 98.100 99.000 10,429,288 99.2833
10 Jan 2020 98.500 100.100 97.250 97.600 81,119,411 97.0289
09 Jan 2020 101.200 107.000 101.100 103.200 5,439,427 104.3798
08 Jan 2020 98.750 101.600 98.600 100.500 3,097,523 100.5950
07 Jan 2020 97.350 103.000 97.100 101.000 3,735,435 100.7417
06 Jan 2020 100.000 102.400 96.800 97.550 3,997,036 98.2303
03 Jan 2020 101.900 103.500 100.400 101.600 2,608,221 101.6599
02 Jan 2020 99.000 101.900 98.350 100.700 3,240,673 100.1561
31 Dec 2019 98.200 99.500 97.750 98.650 1,482,836 98.5209
30 Dec 2019 98.600 99.650 97.950 98.950 2,400,791 98.5801
27 Dec 2019 98.700 99.900 98.700 99.200 2,913,851 99.2068
24 Dec 2019 99.900 100.100 98.500 98.800 1,239,865 99.2602
23 Dec 2019 99.200 100.500 98.100 100.000 1,996,012 99.5559
20 Dec 2019 99.850 99.850 98.250 99.600 3,466,300 99.1518
19 Dec 2019 99.900 99.950 98.050 99.850 1,685,711 99.5041
18 Dec 2019 97.800 99.650 97.500 99.650 5,096,425 98.8202
Summary
Current 2 Weeks
(08 Jan 2020 to 21 Jan 2020)
98.750 107.600 97.250 104.000 134,770,161 -
Previous 2 Weeks
(20 Dec 2019 to 07 Jan 2020)
99.850 107.600 97.250 101.000 27,081,020 -
4 Weeks from
(22 Nov 2019 to 19 Dec 2019)
89.050 107.600 88.950 99.850 64,590,794 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.